Elma Paredes-Aragón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elma Paredes-Aragón has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Irene Gómez-Oropeza
3 shared publicationsDaniela Deustúa-Hernández
2 shared publications- Diego Pichardo-Rojas
Instituto Nacional de Neurología y Neurocirugía “Manuel Velasco Suárez”, Mexico City, Mexico
2 shared publications - Laura Elena Hernández-Vanegas
Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez", Ciudad de México, Mexico
2 shared publications - Sonia Iliana Mejía-Pérez
Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez", Ciudad de México, Mexico
2 shared publications Ashuin Kammar- García
1 shared publication
Latest Publications
- 6 February 2026
- Published by Elsevier in Epilepsy Research
- Vol. 221, 107750
Challenges to epilepsy surgery referral in Mexico: Results from a nationwide survey of primary care physicians and specialists
- 6 February 2026
- Published by Elsevier in Epilepsy Research
- Vol. 221, 107750
Challenges to epilepsy surgery referral in Mexico: Results from a nationwide survey of primary care physicians and specialists
- Open Access
- 4 February 2026
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 33
Real-world Data on Adult Status Epilepticus from Latin America: Clinical Characteristics and Outcomes in a Mexican Tertiary Center
- 4 February 2026
- Published by Elsevier in Epilepsy & Behavior Reports
- Vol. 33
Open AccessReal-world Data on Adult Status Epilepticus from Latin America: Clinical Characteristics and Outcomes in a Mexican Tertiary Center
- Open Access
- 19 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Functional Neurological Disorder Presenting as Apparent Drug-Resistant Seizures: A Case Report on Emphasizing the Role of Early Diagnosis
Functional neurological disorder (FND) is a complex and frequently misdiagnosed condition characterized by neurological symptoms such as motor events, sensory deficits, or altered consciousness caused by brain network dysfunction rather than structural abnormalities. Despite its prevalence, FND remains stigmatized and underrecognized, mainly due to its historical association with psychological factors and its disproportionate impact on women. We present the case of a 19-year-old biological woman with a seven-year history of presumed epilepsy, treated with multiple antiseizure medications despite inconclusive findings on brain magnetic resonance imaging (MRI) and EEG. Her medical history included post-traumatic stress disorder and a family history of epilepsy involving both first and second degree relatives, including one case associated with tuberous sclerosis. At 18 years of age, she was hospitalized after several functional seizures requiring orotracheal intubation, though EEG and brain MRI remained normal. She continued to experience functional seizures. A video-EEG eventually recorded multiple events without an electrographic correlate, confirming the FND diagnosis. Following diagnosis, antiseizure medications (ASM) were gradually withdrawn, and she initiated cognitive-behavioral therapy and sertraline. The patient achieved complete resolution of functional events and reported significant improvement. This case highlights the importance of early consideration of FND in patients with drug-resistant seizures and non-correlating diagnostics to avoid unnecessary treatments and improve quality of life.
- 19 December 2025
- Published by Springer Nature in Cureus
- Vol. 17 (12)
Open AccessFunctional Neurological Disorder Presenting as Apparent Drug-Resistant Seizures: A Case Report on Emphasizing the Role of Early Diagnosis
Functional neurological disorder (FND) is a complex and frequently misdiagnosed condition characterized by neurological symptoms such as motor events, sensory deficits, or altered consciousness caused by brain network dysfunction rather than structural abnormalities. Despite its prevalence, FND remains stigmatized and underrecognized, mainly due to its historical association with psychological factors and its disproportionate impact on women. We present the case of a 19-year-old biological woman with a seven-year history of presumed epilepsy, treated with multiple antiseizure medications despite inconclusive findings on brain magnetic resonance imaging (MRI) and EEG. Her medical history included post-traumatic stress disorder and a family history of epilepsy involving both first and second degree relatives, including one case associated with tuberous sclerosis. At 18 years of age, she was hospitalized after several functional seizures requiring orotracheal intubation, though EEG and brain MRI remained normal. She continued to experience functional seizures. A video-EEG eventually recorded multiple events without an electrographic correlate, confirming the FND diagnosis. Following diagnosis, antiseizure medications (ASM) were gradually withdrawn, and she initiated cognitive-behavioral therapy and sertraline. The patient achieved complete resolution of functional events and reported significant improvement. This case highlights the importance of early consideration of FND in patients with drug-resistant seizures and non-correlating diagnostics to avoid unnecessary treatments and improve quality of life.
- Open Access
- 21 June 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (4) , 1176-1186
Long‐term outcomes of corpus callosotomy in adult patients with drug‐resistant epilepsy: Results from a single neurosurgical center in Mexico
Objective: Corpus callosotomy (CC) is a commonly indicated palliative surgery for drug‐resistant epilepsy (DRE). While younger age at the time of surgery is a well‐established positive prognostic factor, there is limited evidence on long‐term outcomes in adult patients with DRE. A study that evaluates seizure control at various follow‐up points is necessary to better understand the outcomes of CC. Methods: In this retrospective longitudinal cohort, we included adult CC patients operated on by our institution's epilepsy surgery service between 1993 and 2023. We compiled epilepsy etiology, preoperative seizure frequency, and postoperative seizure outcomes at 3 years of follow‐up. Our outcomes were seizure freedom and response rate (50% frequency decrease from preoperative). Results: We analyzed data from 63 patients. The most common indication for CC was DRE due to Lennox–Gastaut Syndrome. Median seizure frequency had a significant decrease from preoperative (70 seizures per month [spm], IQR = 16–210) to the 1 year of follow‐up (4 spm, IQR = 0–20, p = p = 3 years of follow‐up (7 spm, IQR = 2.25–30, p = p = 0.032), while the overall response rate of our sample remained consistent, being 81% at 1‐year follow‐up and 70% at the long‐term follow‐up ( p = 0.20). There were 10 postoperative complications, with 5 cases of neurological deficits. Significance: We identified that CC effectively decreases seizure frequency in adult patients with DRE. The reduction of seizure frequency after CC remained consistent after the first postoperative year. Prospective clinical trials are needed to better understand the long‐term outcomes of CC in adults. Plain Language Summary: This study analyzed the outcomes of corpus callosotomy (CC) in adult patients with drug‐resistant epilepsy. We identified that CC is a safe and effective long‐term treatment, with 70% of patients experiencing significant seizure reduction and 11% achieving seizure freedom. While most existing evidence supports CC in children, our findings support its efficacy in adult patients as well.
- 21 June 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (4) , 1176-1186
Open AccessLong‐term outcomes of corpus callosotomy in adult patients with drug‐resistant epilepsy: Results from a single neurosurgical center in Mexico
Objective: Corpus callosotomy (CC) is a commonly indicated palliative surgery for drug‐resistant epilepsy (DRE). While younger age at the time of surgery is a well‐established positive prognostic factor, there is limited evidence on long‐term outcomes in adult patients with DRE. A study that evaluates seizure control at various follow‐up points is necessary to better understand the outcomes of CC. Methods: In this retrospective longitudinal cohort, we included adult CC patients operated on by our institution's epilepsy surgery service between 1993 and 2023. We compiled epilepsy etiology, preoperative seizure frequency, and postoperative seizure outcomes at 3 years of follow‐up. Our outcomes were seizure freedom and response rate (50% frequency decrease from preoperative). Results: We analyzed data from 63 patients. The most common indication for CC was DRE due to Lennox–Gastaut Syndrome. Median seizure frequency had a significant decrease from preoperative (70 seizures per month [spm], IQR = 16–210) to the 1 year of follow‐up (4 spm, IQR = 0–20, p = p = 3 years of follow‐up (7 spm, IQR = 2.25–30, p = p = 0.032), while the overall response rate of our sample remained consistent, being 81% at 1‐year follow‐up and 70% at the long‐term follow‐up ( p = 0.20). There were 10 postoperative complications, with 5 cases of neurological deficits. Significance: We identified that CC effectively decreases seizure frequency in adult patients with DRE. The reduction of seizure frequency after CC remained consistent after the first postoperative year. Prospective clinical trials are needed to better understand the long‐term outcomes of CC in adults. Plain Language Summary: This study analyzed the outcomes of corpus callosotomy (CC) in adult patients with drug‐resistant epilepsy. We identified that CC is a safe and effective long‐term treatment, with 70% of patients experiencing significant seizure reduction and 11% achieving seizure freedom. While most existing evidence supports CC in children, our findings support its efficacy in adult patients as well.
- Open Access
- 18 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e75964
Status Epilepticus Treated With Vagus Nerve Stimulation in an Adult With Cortical Dysplasia: A Case Report
Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures, with significant risks of neuronal injury and mortality. This case presents a 60-year-old man with drug-resistant epilepsy and a history of recurrent prolonged seizures. His seizures began in early childhood and persisted despite multiple anti-seizure medications. Notably, his semiology included the chapeau de gendarme sign, suggesting an involvement of the anterior cingulate cortex and frontal lobe. Brain MRI revealed a cortical dysplasia in the right inferior frontal gyrus. Given his high risk of sudden unexpected death in epilepsy (SUDEP) due to frequent generalized tonic-clonic seizures, vagus nerve stimulation (VNS) was considered an alternative therapy, with future evaluation for a surgical intervention involving lesionectomy. Following VNS implantation, his SE was arrested with standard titration, and within six months, the patient achieved seizure freedom. This case demonstrates the use of VNS in controlling SE. Further research is necessary to determine optimal protocols for VNS use in SE.
- 18 December 2024
- Published by Springer Nature in Cureus
- Vol. 16 (12) , e75964
Open AccessStatus Epilepticus Treated With Vagus Nerve Stimulation in an Adult With Cortical Dysplasia: A Case Report
Status epilepticus (SE) is a neurological emergency characterized by prolonged seizures, with significant risks of neuronal injury and mortality. This case presents a 60-year-old man with drug-resistant epilepsy and a history of recurrent prolonged seizures. His seizures began in early childhood and persisted despite multiple anti-seizure medications. Notably, his semiology included the chapeau de gendarme sign, suggesting an involvement of the anterior cingulate cortex and frontal lobe. Brain MRI revealed a cortical dysplasia in the right inferior frontal gyrus. Given his high risk of sudden unexpected death in epilepsy (SUDEP) due to frequent generalized tonic-clonic seizures, vagus nerve stimulation (VNS) was considered an alternative therapy, with future evaluation for a surgical intervention involving lesionectomy. Following VNS implantation, his SE was arrested with standard titration, and within six months, the patient achieved seizure freedom. This case demonstrates the use of VNS in controlling SE. Further research is necessary to determine optimal protocols for VNS use in SE.